Search

everythinglearnresearchcommunity

for

Search:↓

The trial aims to understand how obesity and lifestyle affect circadian rhythms in people with schizophrenia and bipolar disorder.

Hair loss increases with age; alcohol raises risk, more female partners lowers it.

Some drugs can cause rare but potentially deadly skin reactions, and early treatment and avoiding the drug again are key.

The study concludes that mutations in the AEBP1 gene can cause a form of Ehlers-Danlos syndrome and should be considered in diagnosis.

Spironolactone, a heart and liver drug, has new uses including cancer treatment, viral infection prevention, and skin condition improvement.

Hair greying is linked to reduced ATM protein in hair cells, which protects against stress and damage.

Football players can get many skin conditions from their sport, which need different treatments and can be prevented with good hygiene and protection.

Melatonin may help with nerve pain, a hepatitis C drug is effective but has side effects, a treatment for mouth sores works but can cause blood issues, ear reconstruction with an implant is safe, HIV transmission from mother to child in Taiwan is now 0% with treatment, certain blood problems are more common in people with a tongue condition, a gene and being overweight are linked to hair loss in some women, a new technique could reduce radiation for lung nodule patients, a hepatitis treatment may lower cancer recurrence after a procedure, and adding extra screening improves tuberculosis detection in patients with lung infections.

Certain skin drugs and topical agents, including some natural extracts and fragrances, can cause allergic reactions. Some hair dyes and extensions, as well as minoxidil, a hair growth treatment, can also cause allergies. Botulinum toxin A can effectively reduce sweat but may have temporary side effects.

Women are more likely to have long-term post-COVID symptoms than men.

People with alopecia areata may have a higher risk of hearing loss.

Alopecia areata and its severe forms are becoming more common, especially among females, adults, and people in the Northeast.

Higher iron levels in hair may increase the risk of esophageal cancer.

Serotonergic antidepressants can significantly increase the risk of erectile dysfunction and have a small risk of causing irreversible sexual dysfunction.

5-alpha reductase inhibitors and spironolactone don't increase gynecological tumor risk, glucagon-like-peptide-1 receptor agonists may increase alopecia risk, sanitary pads can cause dermatitis, early hidradenitis suppurativa intervention is crucial for Hispanic patients, community education boosts skin cancer awareness, metformin may improve skin cancer survival, LNG-IUDs can increase acne risk, machine learning accurately detects basal cell carcinoma, JAK-inhibitors may raise miscarriage risk, inclusive skincare ads affect those with darker skin, and CCCA in Black women might involve autoimmunity.

Eating more antioxidant-rich foods and less alcohol may help reduce hair loss.

Long-term, low-dose finasteride may reduce the risk of benign prostatic hyperplasia and prostate cancer.

Certain elements in maternal hair are linked to higher gestational diabetes risk and lower infant mental development.

Eight blood metabolites are linked to causing allergic conjunctivitis, offering new ways to predict and treat it.

The scalp microbiome is more diverse and may be more important in hair loss than the gut microbiome.

Low calcium levels and dietary issues are linked to hair loss, suggesting a combined Ayurvedic and nutritional approach for prevention.

Low calcium and dietary issues may contribute to hair loss.

Hair products don't affect lupus development or severity.

VYN201 shows promise as a safe and effective treatment for non-segmental vitiligo.

Low vitamin D levels are linked to Alopecia Areata.

CG2001 is safe and well-tolerated for treating hair loss, with fewer side effects than oral finasteride.

SOD1 and KL are promising targets for new hair loss treatments.

Drugs for prostate enlargement and hair loss were not linked to increased risk of depression or suicide.

Ixekizumab is safe for long-term use with low rates of major heart-related events.

Dutasteride use can lead to a stable decline in sexual function that is not affected by age or prostate size.